Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30

Bone Marrow Transplantation

Volumn 47, Issue 4, 2012, Pages 473-482

  Grulke, N ^a,b   Albani, C ^c,d   Bailer, H ^a,b  

^a Klinische Forschung   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c Schussental Klinik gGmbH   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

haematopoietic stem cell transplantation; QLQ C30; quality of life; reference data; review

Indexed keywords

ANOREXIA; COGNITION; CONSTIPATION; DAILY LIFE ACTIVITY; DYSPNEA; EMOTIONALITY; FATIGUE; FUNCTIONAL STATUS; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INSOMNIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA AND VOMITING; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE CORE QUESTIONNAIRE; REFERENCE VALUE; REVIEW; SCORING SYSTEM; SOCIAL STATUS; SYSTEMATIC REVIEW;

EUROPEAN UNION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOKINES; MALE; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SOCIETIES, MEDICAL;

EID: 84859465929     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.107     Document Type: Review

References (64)

1. Aaronson NK, Ahmedzai S, Bergmann B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365-376. (Pubitemid 23073154)
2. Efficace F, Bottomley A, Coens C. Which is the most frequently used health-related quality of life (HRQOL) measure in cancer clinical trials? (abstract). Psychooncology 2006; 15(2 (Suppl)): S135-S136.
3. Kuchler T, Behrend M. Der onkologische Patient-Lebens-qualitat und supportive Therapie. Im Focus Onkologie 2001; 4: 49-52.
4. Fayers P, Bottomley A. Quality of life research within the EORTC-the EORTC QLQ-C30. Eur J Cancer 2002; 38(Suppl 4): S125-S133. (Pubitemid 34169774)
5. Velikova G, Weis J, Hjermstad MJ, Kopp M, Morris P, Watson M et al. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Eur J Cancer 2007; 43: 87-94. (Pubitemid 46054476)
6. Fayers PM, Aaronson NK, Bjordal K, Curran D, Groenvold N. The EORTC QLQ-C30 Scoring Manual. 2 edn. European Organization for Research and Treatment of Cancer: Brussels, Belgium, 1999.
7. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C et al. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer 2006; 14: 988-998. (Pubitemid 44451304)
8. Klee M, Groenvold M, Machin D. Quality of life of Danish women: population-based norms for the EORTC QLQ-C30. Qual Life Res 1997; 6: 27-34. (Pubitemid 27110092)
9. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ-30 (+3). J Clin Oncol 1998; 16: 1188-1196. (Pubitemid 28108757)
10. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30: reference values from a large sample of the Swedish population. Acta Oncol 2000; 39: 477-484.
11. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345-1351. (Pubitemid 32588744)
12. Fayers PM. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2001; 37: 1331-1334. (Pubitemid 32588741)
13. Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008; 42: 819-827.
14. Hendriks MGJ, Schouten HC. Quality of life after stem cell transplantation: a patient, partner and physician perspective. Eur J Int Med 2002; 13: 52-56. (Pubitemid 34139942)
15. Goodman KA, Riedel E, Serrano V, Gulati S, Moskowitz C, Yahalom J. 2584: Health-related quality of life in long-term survivors of autologous hematopoietic-cell transplantation for refractory and relapsed Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2006; 66(3, Supplement 1) S534-S535 (abstract 2584).
16. Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Gundy C et al. EORTC QLQ-C30 Reference Values (online: http://groups.eortc.be/qol/ downloads/reference-values-manual 2008.pdf,accessed Jan 14, 2009) European Organization for Research and Treatment of Cancer-Quality of Life Department: Brussels, Belgium, 2008.
17. Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 1995; 40: 479-490.
18. Molassiotis A, Morris PJ. Quality of life in patients with chronic myeloid leukemia after unrelated donor bone marrow transplantation. Cancer Nurs 1999; 22: 340-349. (Pubitemid 29466342)
19. Zittoun R, Achard S, Ruszniewski M. Assessment of quality of life during intensive chemotherapy or bone marrow transplantation. Psychooncology 1999; 8: 64-73. (Pubitemid 29116267)
20. Watson M, Buck G, Wheatley K, Homewood JR, Goldstone AH, Rees JKH et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004; 40: 971-978. (Pubitemid 38496252)
21. Wettergren L, Langius A, Bjorkholm M, Bjorvell H. Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation-a prospective study. Bone Marrow Transplant 1997; 20: 497-502. (Pubitemid 27434899)
22. Olivieri A, Capelli D, Montanari M, Brunori M, Massidda D, Poloni A et al. Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplant 2001; 27: 1189-1195. (Pubitemid 32600292)
23. Gulbrandsen N, Hjermstad MJ, Wisloff F. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur J Haematol 2004; 72: 172-180. (Pubitemid 38250794)
24. Poppelreuter M, Weis J, Mumm A, Orth HB, Bartsch HH. Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 79-90.
25. Harder H, Duivenvoorden HJ, van Gool AR, Cornelissen JJ, van den Bent MJ. Neurocognitive functions and quality of life in haematological patients receiving haematopoietic stem cell grafts: a one-year follow-up pilot study. J Clin Exp Neuro-psychol 2006; 28: 283-293.
26. Hjermstad MJ, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol 1999; 17: 706-718. (Pubitemid 29075260)
27. Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 2004; 34: 257-266. (Pubitemid 39136833)
28. Hacker ED, Ferrans CE. Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs 2003; 26: 312-322. (Pubitemid 36903886)
29. Kamm M. Veränderungen von Indikatoren der Lebensqualität' nach Hochdosis-Chemotherapie (Dissertation; accessible online: http://webdoc.sub. gwdg.de/diss/2004/kamm/kamm.pdf) Uni-versitat Gottingen: Gottingen, 2004.
30. Frick E, Borasio GD, Zehentner H, Fischer N, Bumeder I. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psychooncology 2004; 13: 116-124. (Pubitemid 38247768)
31. Frick E, Rieg-Appleson C, Tyroller M, Bumeder I. Social support, affectivity, and the quality of life of patients and their support-givers prior to stem cell transplantation. J Psychosoc Oncol 2005; 23: 15-34. (Pubitemid 43856719)
32. Baumann FT. Auswirkungen von Bewegungstherapie auf die physische und psychische Verfassung von Patienten im Rahmen einer hämatopoetischen Stammzelltransplantation (Dissertation). Institut fur Rehabilitation und Behindertensport der Deutschen Sporthochschule Koln: Koln, 2005.
33. Frick E, Ramm G, Bumeder I, Schulz-Kindermann F, Tyroller M, Fischer N et al. Social support and quality of life of patients prior to stem cell or bone marrow transplantation. Br J Health Psychol 2006; 11: 451-462. (Pubitemid 44342744)
34. Hacker ED, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J et al. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 2006; 33: 614-624. (Pubitemid 44870229)
35. Schulz-Kindermann F, Mehnert A, Scherwath A, Schirmer L, Schleimer B, Zander AR et al. Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 2007; 39: 789-799. (Pubitemid 46901978)
36. Grulke N. Psychosoziale Prädiktoren. Eine Studie zur Überle-benszeit von Patienten unter allogener hämatopoietischer Stammzelltransplantation. Ulmer Textbank: Ulm, 2007.
37. Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L. A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 2009; 43: 725-737.
38. Rischer J, Scherwath A, Zander AR, Koch U, Schulz-Kindermann F. Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant 2009; 44: 121-128.
39. Wettergren L, Sprangers M, Bjorkholm M, Langius-Eklof A. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument. Psychooncology 2008; 17: 338-346. (Pubitemid 351513682)
40. Brandberg Y, Michelson H, Nilsson B, Bolund C, Erikstein B, Hietanen P et al. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. J Clin Oncol 2003; 21: 3659-3664. (Pubitemid 46594060)
41. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002; 30: 785-792. (Pubitemid 36004307)
42. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27-32. (Pubitemid 28425171)
43. Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM. Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576-591.
44. Uyl-de Groot CA, Buijt I, Gloudemans IJM, Ossenkoppele GJ, Berg HP, Huijgens PC. Health related quality of life in patients with multiple myeloma undergoing a double transplantation. Eur J Haematol 2005; 74: 136-143. (Pubitemid 40175318)
45. Caocci G, Pisu S, Argiolu F, Giardini C, Locatelli F, Vacca A et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant 2006; 37: 165-169. (Pubitemid 43108808)
46. Gulbrandsen N, Wisloff F, Nord E, Lenhoff S, Hjorth M, Westin J et al. Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs melphalan plus prednisone in patients younger than 60 years with multiple myeloma. Eur J Haematol 2001; 66: 328-336. (Pubitemid 32552168)
47. Hensel M, Egerer G, Schneeweiss A, Goldschmidt H, Ho AD. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol 2002; 13: 209-217. (Pubitemid 34704971)
48. Harder H, Cornelissen JJ, Van-Gool AR, Duivenvoorden HJ, Eijkenboom WMH, Van den Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 2002; 95: 183-192. (Pubitemid 34743497)
49. Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 1997; 20: 307-315. (Pubitemid 27389240)
50. Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 2007; 66: 108-118. (Pubitemid 46366616)
51. Hsu C, Wang J-D, Hwang J-S, Tien H-F, Chang S-M, Cheng A-L et al. Survival-weighted health profile for long-term survivors of acute myelogenous leukemia. Qual Life Res 2003; 12: 503-517. (Pubitemid 37056042)
52. Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619-626. (Pubitemid 35414812)
53. Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008; 93: 826-833. (Pubitemid 351835978)
54. Hayden PJ, Keogh F, Conghaile MN, Carroll M, Crowley M, Fitzsimon N et al. A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukemia in first chronic phase. Bone Marrow Transplant 2004; 34: 545-556. (Pubitemid 39264047)
55. Gielissen MFM, Schattenberg AVM, Verhagen CAHHVM, Rinkes MJ, Bremmers MEJ, Bleijenberg G. Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant 2007; 39: 595-603. (Pubitemid 46722841)
56. Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP et al. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol 2005; 74: 304-308. (Pubitemid 40461150)
57. Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC et al. Associations of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20: 2118-2126. (Pubitemid 34408803)
58. Grulke N, Larbig W, Kachele H, Bailer H. Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. Psychoon-cology 2008; 17: 480-487. (Pubitemid 351802757)
59. van Belle G. Statistical Rules of Thumb. Wiley: New York, 2002.
60. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004; 104: 1898-1906. (Pubitemid 39202304)
61. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. J Am Med Assoc 2004; 291: 2335-2343. (Pubitemid 38656300)
62. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-144. (Pubitemid 28041591)
63. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555-567. (Pubitemid 27006967)
64. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2 edn. Lawrence Erlbaum Associates: Hillsdale, New Jersey, 1988.